252 related articles for article (PubMed ID: 17356006)
21. EGb 761 is a neuroprotective agent against beta-amyloid toxicity.
Bastianetto S; Quirion R
Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):693-7. PubMed ID: 12396081
[TBL] [Abstract][Full Text] [Related]
22. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
23. Effects of gintonin-enriched fraction on hippocampal cell proliferation in wild-type mice and an APPswe/PSEN-1 double Tg mouse model of Alzheimer's disease.
Kim HJ; Kim DJ; Shin EJ; Lee BH; Choi SH; Hwang SH; Rhim H; Cho IH; Kim HC; Nah SY
Neurochem Int; 2016 Dec; 101():56-65. PubMed ID: 27765516
[TBL] [Abstract][Full Text] [Related]
24. Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition.
Bartolome F; de la Cueva M; Pascual C; Antequera D; Fernandez T; Gil C; Martinez A; Carro E
Alzheimers Res Ther; 2018 Feb; 10(1):24. PubMed ID: 29458418
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans.
Wu Y; Wu Z; Butko P; Christen Y; Lambert MP; Klein WL; Link CD; Luo Y
J Neurosci; 2006 Dec; 26(50):13102-13. PubMed ID: 17167099
[TBL] [Abstract][Full Text] [Related]
26. Ginkgo biloba extract: cognitive enhancer or antistress buffer.
Ward CP; Redd K; Williams BM; Caler JR; Luo Y; McCoy JG
Pharmacol Biochem Behav; 2002 Jul; 72(4):913-22. PubMed ID: 12062581
[TBL] [Abstract][Full Text] [Related]
27. Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability.
Williams B; Watanabe CM; Schultz PG; Rimbach G; Krucker T
Neurobiol Aging; 2004 Aug; 25(7):955-62. PubMed ID: 15212849
[TBL] [Abstract][Full Text] [Related]
28. Combination of docosahexaenoic acid and Ginko biloba extract improves cognitive function and hippocampal tissue damages in a mouse model of Alzheimer's disease.
Abdelmeguid NE; Khalil MIM; Elhabet R; Sultan AS; Salam SA
J Chem Neuroanat; 2021 Oct; 116():101995. PubMed ID: 34182090
[TBL] [Abstract][Full Text] [Related]
29. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
[TBL] [Abstract][Full Text] [Related]
30. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
[TBL] [Abstract][Full Text] [Related]
31. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
Augustin S; Rimbach G; Augustin K; Schliebs R; Wolffram S; Cermak R
Arch Biochem Biophys; 2009 Jan; 481(2):177-82. PubMed ID: 18996078
[TBL] [Abstract][Full Text] [Related]
32. Hyperbaric Oxygen and Ginkgo Biloba Extract Ameliorate Cognitive and Memory Impairment via Nuclear Factor Kappa-B Pathway in Rat Model of Alzheimer's Disease.
Zhang LD; Ma L; Zhang L; Dai JG; Chang LG; Huang PL; Tian XQ
Chin Med J (Engl); 2015 Nov; 128(22):3088-93. PubMed ID: 26608991
[TBL] [Abstract][Full Text] [Related]
33. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications.
DeFeudis FV; Drieu K
Curr Drug Targets; 2000 Jul; 1(1):25-58. PubMed ID: 11475535
[TBL] [Abstract][Full Text] [Related]
34. Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels.
Yao ZX; Han Z; Drieu K; Papadopoulos V
J Nutr Biochem; 2004 Dec; 15(12):749-56. PubMed ID: 15607648
[TBL] [Abstract][Full Text] [Related]
35. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
36. Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.
Müller M; Cárdenas C; Mei L; Cheung KH; Foskett JK
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13293-8. PubMed ID: 21784978
[TBL] [Abstract][Full Text] [Related]
37. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
Gong B; Vitolo OV; Trinchese F; Liu S; Shelanski M; Arancio O
J Clin Invest; 2004 Dec; 114(11):1624-34. PubMed ID: 15578094
[TBL] [Abstract][Full Text] [Related]
38. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
[TBL] [Abstract][Full Text] [Related]
39. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761.
Smith JV; Luo Y
J Alzheimers Dis; 2003 Aug; 5(4):287-300. PubMed ID: 14624024
[TBL] [Abstract][Full Text] [Related]
40. Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.
Wang CY; Wang ZY; Xie JW; Wang T; Wang X; Xu Y; Cai JH
Neurobiol Aging; 2016 Feb; 38():32-46. PubMed ID: 26827641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
